{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Dr. Paika Podcast","title":"Microdosing Zepbound & Ozempic: How Low Can You Go and Still Keep the Weight Off? (Doctor Explains)","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/9fb6dab0\"></iframe>","width":"100%","height":180,"duration":1170,"description":"#GLP1 #Microdosing #Zepbound #Ozempic #WeightLossMaintenance\nMicrodosing Zepbound & Ozempic: How Low Can You Go and Still Keep the Weight Off?\nYou hit your goal weight. Now the question is: do you have to stay on this dose forever? More and more people are cutting their GLP-1 dose to a fraction or stretching their shots to every 10 to 14 days, hoping to save money, cut side effects, and keep the weight off.\nI'm Dr. Mohammed Paika, a board-certified internal medicine and obesity medicine physician and practicing hospitalist. In this video I break down what the research actually shows about lower-dose GLP-1 maintenance, and what it doesn't show yet.\n🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime Access\nComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.\nhttps://www.drmohammedpaika.com\n📩 FREE GLP-1 Diet Cookbook + Weekly Newsletter\nGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.\nhttps://www.drmohammedpaika.com/newsletter\nTIMESTAMPS\n0:00 Do I have to stay on this dose forever?\n1:24 The rebound: what happens when you stop\n2:49 Why microdosing is trending now\n4:01 What is microdosing? The minimal effective dose\n5:02 Two approaches: dose reduction vs. interval spacing\n6:01 What happens at lower doses\n7:35 Muscle preservation\n9:14 What the evidence says: SURMOUNT-MAINTAIN\n12:03 Why the weight comes back: the set point\n13:35 Why people want a lower dose: cost, supply, side effects\n14:16 The 4 risks of going too low\n17:06 My step-down framework\n18:38 How low can you go? The bottom line\nREFERENCES\n1. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564.\n2. Aronne LJ, et al. Continued treatment with tirzepatide for...","thumbnail_url":"https://img.transistorcdn.com/9qIr9DvwV8ODN3d9cHtpN76KWo0AHFHUFFi87mNWtws/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lNGNl/MTliYWE0MmYyMTY1/NWNjZTA2MWU0Zjgx/N2I5YS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}